With regards to neurology, all CGRP-targeted therapies tested for the acute treatment and prevention of migraine have consistently produced positive results to date, strongly supporting the evolving role of CGRP in migraine pathophysiology. The gene discussed is CALCA; the disease is migraine disorder.